Table 5.
Socio-demographic predictors of lifetime treatment contact for any mood disorder
| Country | Sex | χ2 | Cohort (age at interview) | χ2 | Age of onset | χ2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | Age 18-34 | Age 35-49 | Age 50-64 | Early | Early-average | Late-average | |||||||||||
| OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | ||||
| The Americas | |||||||||||||||||
| Colombia | 1.5 | (0.9-2.3) | 2.7 | 3.2 | (1.3-7.7) | 1.7 | (1.0-3.2) | 1.0 | - | 6.7 | 0.2 | (0.1-0.4) | 0.3 | (0.2-0.7) | 0.8 | (0.5-1.3) | 33.6 |
| Mexico | 1.6 | (1.0-2.4) | 4.6 | 2.1 | (0.9-4.9) | 1.7 | (0.8-3.3) | 1.0 | - | 3.1 | 0.3 | (0.2-0.6) | 0.5 | (0.2-0.9) | 0.8 | (0.4-1.6) | 25.1 |
| USA | 1.3 | (1.1-1.5) | 10.2 | 4.4 | (3.2-6.1) | 3.1 | (2.3-4.1) | 1.9 | (1.4-2.6) | 115.5 | 0.2 | (0.1-0.3) | 0.3 | (0.2-0.3) | 0.4 | (0.3-0.6) | 176.7 |
| Europe | |||||||||||||||||
| Belgium a | 1.4 | (0.9-2.1) | 2.5 | 3.9 | (1.2-12.5) | 3.9 | (1.5-10.5) | 1.7 | (0.7-4.0) | 14.5 | 0.2 | (0.1-0.6) | 0.4 | (0.2-0.9) | 0.6 | (0.4-0.9) | 14.2 |
| France a | 1.3 | (0.9-1.8) | 2.9 | 5.7 | (3.1-10.5) | 4.4 | (2.4-8.0) | 2.0 | (1.1-3.5) | 44.3 | 0.2 | (0.1-0.4) | 0.4 | (0.2-0.8) | 0.6 | (0.3-1.2) | 54.9 |
| Germany a | 1.2 | (0.8-2.0) | 0.9 | 1.9 | (0.7-5.1) | 1.2 | (0.6-2.8) | 1.2 | (0.5-2.5) | 6.3 | 0.3 | (0.1-0.6) | 0.5 | (0.2-1.0) | 1.1 | (0.5-2.1) | 22.5 |
| Italy a | 1.4 | (0.9-2.0) | 2.6 | 1.4 | (0.7-2.8) | 1.6 | (0.8-2.9) | 1.1 | (0.6-2.1) | 2.8 | 0.4 | (0.2-0.8) | 0.8 | (0.4-1.6) | 0.8 | (0.4-1.4) | 15.7 |
| Netherlands a | 0.9 | (0.7-1.3) | 0.1 | 3.9 | (1.7-8.9) | 2.7 | (1.6-4.4) | 1.0 | - | 18.5 | 0.1 | (0.0-0.3) | 0.3 | (0.1-0.6) | 0.5 | (0.3-0.8) | 27.1 |
| Spain a | 1.2 | (0.8-1.8) | 1.1 | 1.9 | (0.9-3.8) | 2.7 | (1.4-5.1) | 1.3 | (0.8-2.1) | 11.3 | 0.4 | (0.2-0.8) | 0.4 | (0.2-0.9) | 0.7 | (0.4-1.2) | 8.3 |
| Africa and Middle East | |||||||||||||||||
| Israel | 1.1 | (0.9-1.5) | 0.7 | 5.4 | (2.9-10.0) | 4.0 | (2.3-6.8) | 2.3 | (1.4-3.7) | 30.9 | 0.3 | (0.2-0.6) | 0.4 | (0.2-0.6) | 0.6 | (0.4-1.0) | 20.8 |
| Lebanon | 1.1 | (0.7-1.8) | 0.2 | 13.8 | (2.3-83.0) | 8.8 | (1.5-51.1) | 5.0 | (0.8-30.8) - | 13.4 | 0.4 | (0.2-0.8) | 0.2 | (0.1-0.7) | 0.7 | (0.3-1.4) | 10.6 |
| Nigeria | 1.4 | (0.5-3.6) | 0.5 | 2.7 | (0.3-22.4) | 0.5 | (0.1-3.7) | 1.0 | - | 6.8 | 2.6 | (0.2-33.6) | 1.2 | (0.0-31.2) | 3.3 | (0.3-41.1) | 3.0 |
| Asia and the Pacific | |||||||||||||||||
| Japan | 1.6 | (0.8-3.5) | 1.7 | 3.9 | (1.1-13.4) | 2.0 | (0.7-6.2) | 1.5 | (0.6-4.2) | 5.0 | 0.2 | (0.0-0.6) | 0.5 | (0.2-1.3) | 0.8 | (0.4-1.9) | 9.8 |
| PR China | 0.8 | (0.2-3.6) | 0.1 | 0.7 | (0.2-2.9) | 0.4 | (0.1-1.3) | 1.0 | - | 2.4 | 0.5 | (0.1-3.3) | 0.4 | (0.1-1.7) | 0.5 | (0.1-1.9) | 2.3 |
| Oceania | |||||||||||||||||
| New Zealand | 1.4 | (1.2-1.6) | 16.9 | 3.7 | (2.7-5.2) | 2.3 | (1.7-3.1) | 1.6 | (1.2-2.2) | 84.1 | 0.2 | (0.2-0.3) | 0.3 | (0.3-0.4) | 0.6 | (0.5-0.8) | 205.6 |
a Used major depressive episode instead of any mood disorder